Community Academic Profiles

Hugh Solvason

Treatment of Schizoaffective Disorder Using Mifepristone

Contact Information

Central Contact:

Jessica Hawkins (650) 723-8323
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Jessica Hawkins (650) 723-8323
To view all clinical trials at Stanford, please see the Clinical Trials Directory.

Brief

This study tests the hypothesis that mifepristone will diminish cognitive distortion and alleviate psychosis in patients with schizoaffective disorder.

Recruiting Status:

Terminated

Stanford Recruiting Status:

Terminated

Intervention(s):

  • Drug: Mifepristone

Phase:

Phase 2/Phase 3

Eligibility

Ages Eligible for Study:

18 years to 75 years

Genders Eligible for Study:

Male and Female

Health of Volunteers:

People with the conditions listed in this trial can participate as controls.

Key Inclusion Criteria:

The subjects will be 30 inpatients or outpatients with schizoaffective disorder.

Key Exclusion Criteria:

Subjects must be between the ages of eighteen and seventy-five without major medical problems.

Additional Study Details

Official Title:

Treatment of Schizoaffective Disorder Using Mifepristone

Anticipated start date:

4/7/1998

Lead Sponsor:

Stanford University

Collaborator(s):

  • Pritzker Foundation

Investigator(s):

Study Type:

Interventional

Purpose:

Treatment

Allocation:

Randomized

Masking:

Double Blind

Control:

none

Assignment:

Factorial

Endpoints:

Efficacy

Primary Outcomes:

  • Psychiatric Symptomatology

Total Number to be Enrolled:

30

Total Number to be Enrolled at Stanford:

30

More Information

Trial Unique Id: SU-06012008-1191

Secondary ID(s):

  • 76458

Locations & Contacts

Stanford Locations & Contacts:

Central Contact for This Study:

Jessica Hawkins (650) 723-8323
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Jessica Hawkins (650) 723-8323

Non-Stanford Locations:

The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.

This listing was last updated:

5/21/2009

PLEASE NOTE:

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.

Stanford Medicine Resources:

Footer Links: